Double-Digit Revenue Growth Driven by Strategic Initiatives Across Industrial and Advanced Solutions
Focused on Driving Margin Expansion
MARLBOROUGH, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the third quarter ended September 30, 2026.
| Drie maanden eindigend op 30 september, | Negen maanden eindigend op 30 september, | |||||||||||||||||||||
| (In miljoenen, behalve gegevens per aandeel en percentages) | 2026 | 2025 | Verander | 2026 | 2025 | Verander | ||||||||||||||||
| Inkomsten | $ | 287.5 | $ | 250.8 | 15 | % | $ | 831.6 | $ | 729.3 | 14 | % | ||||||||||
| Brutomarge | 40.7 | % | 39.5 | % | 39.6 | % | 38.7 | % | ||||||||||||||
| Bedrijfsopbrengsten | $ | 20.8 | $ | 7.9 | NM | $ | 17.6 | $ | 9.8 | NM | ||||||||||||
| Brutowinstmarge | 7.2 | % | 3.1 | % | 2.1 | % | 1.3 | % | ||||||||||||||
| Netto-inkomen | $ | 20.3 | $ | 7.5 | 171 | % | $ | 27.1 | $ | 17.8 | 52 | % | ||||||||||
| Winst per verwaterd aandeel | $ | 0.47 | $ | 0.18 | 161 | % | $ | 0.63 | $ | 0.42 | 50 | % | ||||||||||
| Niet-GAAP-cijfers* | ||||||||||||||||||||||
| Aangepaste brutomarge | 41.0 | % | 39.8 | % | 39.9 | % | 39.2 | % | ||||||||||||||
| Aangepaste EBITDA | $ | 51.5 | $ | 37.0 | 39 | % | $ | 135.2 | $ | 101.2 | 34 | % | ||||||||||
| Aangepaste winst per verwaterd aandeel | $ | 0.61 | $ | 0.35 | 74 | % | $ | 1.49 | $ | 0.96 | 55 | % | ||||||||||
*De gecorrigeerde brutomarge, de gecorrigeerde EBITDA en de gecorrigeerde winst per verwaterd aandeel omvatten niet-GAAP-conforme aanpassingen. Een aansluiting tussen de GAAP- en niet-GAAP-cijfers is opgenomen in dit persbericht over de resultaten.
NM - niet zinvol.
Management Comments
“We delivered our fourth consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance,” said Dr. Mark Gitin, Chief Executive Officer of IPG Photonics. “Our performance reflects the strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets. Strong demand for our differentiated welding and additive manufacturing solutions drove growth in Industrial Solutions while disciplined execution of our key strategic initiatives across defense and semiconductor markets led to strong growth in Advanced Solutions. Additionally, I anticipate that our acquisition of Lumibird Medical, which is expected to close in the fourth quarter, will further strengthen our reach, accelerate growth across medical markets, and increase revenue in Advanced Solutions.”
Financiële hoogtepunten
| Drie maanden eindigend op 30 september, | Negen maanden eindigend op 30 september, | ||||||||||||||||
| 2026 | 2025 | Verander | 2026 | 2025 | Verander | ||||||||||||
| Sales applicatie | |||||||||||||||||
| Industriële oplossingen | $ | 239,548 | $ | 214,697 | 12 | % | $ | 704,181 | $ | 607,593 | 16 | % | |||||
| Geavanceerde oplossingen | 47,952 | 36,095 | 33 | % | 127,396 | 121,713 | 5 | % | |||||||||
| Totaal | $ | 287,500 | $ | 250,792 | 15 | % | $ | 831,577 | $ | 729,306 | 14 | % | |||||
Third quarter revenue of $288 million increased 15% year over year, driven by 12% growth in Industrial Solutions and 33% growth in Advanced Solutions. Changes in foreign exchange rates increased revenue by approximately 1%. Industrial Solutions sales, accounting for 83% of total revenue, were driven by strong performance in welding and additive manufacturing applications. Advanced Solutions sales improved, driven by higher sales in semiconductor and defense applications. Emerging growth products accounted for 52% of total revenue, down from 58% in the prior quarter due to product mix. By region, sales increased 14% in Asia and 33% in North America and decreased 1% in Europe on a year-over-year basis.
GAAP gross margin of 40.7% and adjusted gross margin of 41.0% increased year over year, driven by lower product costs and $5.0 million in net tariff refunds recorded in the period, partially offset by lower fixed cost absorption. Net income was $20 million, or $0.47 per diluted share, and adjusted EBITDA was $52 million and adjusted earnings per diluted share (EPS) was $0.61 in the third quarter. During the third quarter, IPG generated $46 million in cash flow from operations and spent $17 million on capital expenditures.
Bedrijfsvooruitzichten en financiële richtlijnen
“Our third quarter book-to-bill was approximately one as we continued to see improved industrial demand and executed on our strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers. As we move forward, we remain focused on driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio,” concluded Dr. Gitin.
For the fourth quarter of 2026, IPG expects revenue of $265 million to $295 million, adjusted gross margin between 37.0% and 40.0% and adjusted operating expenses of $91 million to $94 million. IPG anticipates delivering adjusted earnings per diluted share in the range of $0.30 to $0.60 and adjusted EBITDA in the range of $33 million to $50 million. The guidance assumes no contribution from the acquisition of Lumibird Medical.
As discussed in more detail in the "Safe Harbor" passage of this news release, actual results may differ from this guidance due to various factors including, but not limited to, trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions. The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook that we have provided. This guidance is based upon current market conditions and expectations and is subject to the risks outlined in the Company's reports filed with the SEC and assumes exchange rates relative to the U.S. dollar of euro 0.88, Japanese yen 157 and Chinese yuan 6.74, respectively.
Aanvullende financiële informatie
Additional supplemental financial information is provided in the unaudited Financial Data Workbook and Third Quarter 2026 Earnings Call Presentation available on the investor relations section of the Company's website at investor.ipgphotonics.com.
Herinnering conferentie
The Company will hold a conference call today, November 3, 2026 at 10:00 am ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com.
Neem contact op met
Eugene Fedotoff
Senior Director, Investeerdersrelaties
IPG Photonics Corporation
508-597-4713
efedotoff@ipgphotonics.com
Over IPG Photonics Corporation
Innovation is at the heart of IPG Photonics. As a global leader in laser technology, we apply light to transform the world. From manufacturing to medical and beyond, our breakthrough laser solutions power our customers’ success and expand what's possible. Discover more at www.ipgphotonics.com.
Safe Harbor Statement
Information and statements provided by IPG and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including those statements related to strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets, the expected timing of the closing of our acquisition of Lumibird Medical and the expectation that the acquisition will increase revenue in Advanced Solutions and strengthen our reach and accelerate growth across medical markets, strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers, driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio, revenue, adjusted gross margin and adjusted operating expenses outlook, adjusted earnings per diluted share and adjusted EBITDA guidance, including the expected impact of tariffs, and the impact of the U.S. dollar on our guidance for the fourth quarter of 2026. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and tariff policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC for the fiscal year ended December 31, 2025), IPG's Quarterly Report on Form 10-Q (filed with the SEC for the quarter ended June 30, 2026), and other reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) |
|||||||||||||
| Drie maanden eindigend op 30 september, | Negen maanden eindigend op 30 september, | ||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||
| (In duizenden, behalve gegevens per aandeel) | |||||||||||||
| Netto sales | $ | 287,500 | $ | 250,792 | $ | 831,577 | $ | 729,306 | |||||
| Kosten van sales | 170,446 | 151,787 | 502,500 | 446,916 | |||||||||
| Brutowinst | 117,054 | 99,005 | 329,077 | 282,390 | |||||||||
| Bedrijfskosten: | |||||||||||||
| Sales en marketing | 23,934 | 23,771 | 72,286 | 73,753 | |||||||||
| Onderzoek en ontwikkeling | 31,335 | 30,358 | 95,648 | 88,631 | |||||||||
| Algemeen en administratief | 37,502 | 35,092 | 110,139 | 102,782 | |||||||||
| Afwikkeling van geschillen | - | - | 13,334 | - | |||||||||
| Afschrijvingen wegens waardevermindering | 231 | - | 17,805 | - | |||||||||
| Herstructureringskosten | - | 425 | - | 425 | |||||||||
| Wisselkoersverlies | 3,275 | 1,504 | 2,293 | 7,013 | |||||||||
| Totale bedrijfskosten | 96,277 | 91,150 | 311,505 | 272,604 | |||||||||
| Bedrijfsopbrengsten | 20,777 | 7,855 | 17,572 | 9,786 | |||||||||
| Overige baten, netto: | |||||||||||||
| Rentebaten, netto | 7,688 | 7,283 | 21,720 | 22,728 | |||||||||
| Other (expense) income, net | (50 | ) | 516 | 2,683 | 2,026 | ||||||||
| Totaal overige baten | 7,638 | 7,799 | 24,403 | 24,754 | |||||||||
| Winst vóór belasting | 28,415 | 15,654 | 41,975 | 34,540 | |||||||||
| Voorziening voor winstbelastingen | 8,142 | 8,191 | 14,876 | 16,714 | |||||||||
| Netto-inkomen | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | |||||
| Winst per gewoon aandeel: | |||||||||||||
| Basis | $ | 0.48 | $ | 0.18 | $ | 0.64 | $ | 0.42 | |||||
| Verwaterd | $ | 0.47 | $ | 0.18 | $ | 0.63 | $ | 0.42 | |||||
| Gewogen gemiddelde uitstaande gewone aandelen: | |||||||||||||
| Basis | 42,531 | 42,199 | 42,416 | 42,427 | |||||||||
| Verwaterd | 42,840 | 42,556 | 42,904 | 42,659 | |||||||||
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) |
||||||||
| 30 september, | 31 december, | |||||||
| 2026 | 2025 | |||||||
| (In thousands, except share data) | ||||||||
| ACTIVA | ||||||||
| Vlottende activa: | ||||||||
| Geldmiddelen en kasequivalenten | $ | 710,688 | $ | 403,790 | ||||
| Kortetermijnbeleggingen | 215,304 | 435,538 | ||||||
| Vorderingen, netto | 191,150 | 181,734 | ||||||
| Voorraden | 337,890 | 313,416 | ||||||
| Vooruitbetaalde belastingen | 33,145 | 43,196 | ||||||
| Vooruitbetaalde kosten en andere vlottende activa | 54,460 | 45,766 | ||||||
| Totaal vlottende activa | 1,542,637 | 1,423,440 | ||||||
| Langetermijnbeleggingen | - | 76,533 | ||||||
| Uitgestelde winstbelastingen, netto | 122,235 | 123,889 | ||||||
| Goodwill | 70,281 | 71,735 | ||||||
| Immateriële activa, netto | 42,777 | 49,933 | ||||||
| Materiële vaste activa, netto | 648,326 | 637,516 | ||||||
| Overige activa | 45,787 | 41,234 | ||||||
| Totaal activa | $ | 2,472,043 | $ | 2,424,280 | ||||
| PASSIVA EN EIGEN VERMOGEN | ||||||||
| Kortlopende schulden: | ||||||||
| Crediteuren | $ | 48,782 | $ | 39,288 | ||||
| Overlopende kosten en andere kortlopende verplichtingen | 204,874 | 184,849 | ||||||
| Te betalen belastingen | 3,858 | 9,900 | ||||||
| Totaal kortlopende verplichtingen | 257,514 | 234,037 | ||||||
| Overige langlopende verplichtingen en uitgestelde winstbelastingen | 59,581 | 62,113 | ||||||
| Totaal verplichtingen | 317,095 | 296,150 | ||||||
| Verplichtingen en voorwaardelijke verplichtingen | ||||||||
| Eigen vermogen: | ||||||||
| Common stock, $0.0001 par value, 175,000,000 shares authorized; 57,380,668 and 42,508,140 shares issued and outstanding, respectively, at September 30, 2026; 56,964,939 and 42,127,067 shares issued and outstanding, respectively, at December 31, 2025. |
6 | 6 | ||||||
| Treasury stock, at cost, 14,872,528 and 14,837,872 shares held at September 30, 2026 and December 31, 2025, respectively. |
(1,558,277 | ) | (1,555,629 | ) | ||||
| Extra gestort kapitaal | 1,097,673 | 1,077,172 | ||||||
| Ingehouden winst | 2,672,063 | 2,644,964 | ||||||
| Niet-gerealiseerde resultaten | (56,517 | ) | (38,383 | ) | ||||
| Totaal eigen vermogen | 2,154,948 | 2,128,130 | ||||||
| Totaal passiva en eigen vermogen | $ | 2,472,043 | $ | 2,424,280 | ||||
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) |
||||||||
| Negen maanden eindigend op 30 september, | ||||||||
| 2026 | 2025 | |||||||
| (In duizenden) | ||||||||
| Kasstromen uit bedrijfsactiviteiten: | ||||||||
| Netto-inkomen | $ | 27,099 | $ | 17,826 | ||||
| Aanpassingen om nettowinst aan te sluiten op nettokasstroom uit bedrijfsactiviteiten: | ||||||||
| Afschrijvingen | 47,377 | 46,799 | ||||||
| Afschrijvingen wegens waardevermindering | 17,805 | - | ||||||
| Voorzieningen voor voorraden, garanties en dubieuze debiteuren | 33,594 | 31,766 | ||||||
| Andere | 25,081 | 21,119 | ||||||
| Changes in assets and liabilities that provided (used) cash: | ||||||||
| Debiteuren en crediteuren | 1,535 | 18,787 | ||||||
| Voorraden | (60,189 | ) | (52,005 | ) | ||||
| Andere | (13,771 | ) | (37,757 | ) | ||||
| Nettokasstroom uit bedrijfsactiviteiten | 78,531 | 46,535 | ||||||
| Kasstromen uit investeringsactiviteiten: | ||||||||
| Aankopen van en stortingen op materiële vaste activa | (54,437 | ) | (60,907 | ) | ||||
| Opbrengst van sales van materiële vaste activa | 2,204 | 605 | ||||||
| Aankoop van beleggingen | (360,732 | ) | (866,402 | ) | ||||
| Purchases of equity investment | (8,000 | ) | - | |||||
| Opbrengsten uit vervallen beleggingen | 663,124 | 633,731 | ||||||
| Van de koper ontvangen aanbetaling voor activa die bestemd zijn voor verkoop | 2,000 | - | ||||||
| Andere | 111 | 69 | ||||||
| Netto kasstroom uit (gebruikt bij) investeringsactiviteiten | 244,270 | (292,904 | ) | |||||
| Kasstromen uit financieringsactiviteiten: | ||||||||
| Payments for taxes related to net share settlement of equity awards less proceeds from issuance of common stock under employee stock option and purchase plans |
(11,053 | ) | (4,316 | ) | ||||
| Aankoop van eigen aandelen, na aftrek van accijns, tegen aanschaffingswaarde | (2,648 | ) | (46,603 | ) | ||||
| Nettokasstroom gebruikt voor financieringsactiviteiten | (13,701 | ) | (50,919 | ) | ||||
| Effect van wisselkoersschommelingen op geldmiddelen, kasequivalenten en voor verkoop aangehouden geldmiddelen | (1,727 | ) | 23,274 | |||||
| Net increase (decrease) in cash, cash equivalents and cash held for sale | 307,373 | (274,014 | ) | |||||
| Geldmiddelen en kasequivalenten - Begin van de periode | 403,790 | 620,040 | ||||||
| Geldmiddelen, kasequivalenten en voor verkoop aangehouden geldmiddelen — Einde van de periode | $ | 711,163 | $ | 346,026 | ||||
| Aanvullende informatieverschaffing over kasstroominformatie: | ||||||||
| Contant betaald voor rente | $ | 54 | $ | 136 | ||||
| Contant betaalde inkomstenbelasting, na aftrek van terugbetalingen | $ | 9,273 | $ | 44,258 | ||||
| IPG PHOTONICS CORPORATION AANVULLEND OVERZICHT VAN NIET-GAAP FINANCIËLE MAATSTAVEN (NIET GECONTROLEERD) |
||||||||
Gebruik van niet binnen GAAP gedefinieerde aangepaste financiële informatie
We refer to certain financial measures that are not recognized under United States generally accepted accounting principles (“GAAP”) and are provided as supplemental information to enhance understanding of the Company’s financial performance. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measure presented by the Company. The following information provides the definition of adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted net earnings per share (EPS), and adjusted tax rate as presented, which are financial measures that are not calculated or presented in accordance with GAAP, and reconciliation to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS, and an adjusted tax rate as supplemental information and in addition to the financial measures presented by the Company that are calculated and presented in accordance with GAAP.
We define adjusted gross profit as reported gross profit, adjusted for non-recurring, infrequent, or unusual charges, including acquisition and integration charges and amortization of acquisition-related intangibles.
We definiëren de gecorrigeerde brutomarge als de gecorrigeerde brutowinst gedeeld door de totale omzet.
We define adjusted operating expense and resultant adjusted operating income as reported operating expenses and resultant operating income, adjusted for non-recurring, infrequent, or unusual charges, including impairment charges, settlement and fees of litigation matters, restructuring charges, acquisition and integration charges, amortization of acquisition-related intangibles, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.
Wij definiëren EBITDA als de nettowinst vermeerderd met rentelasten (of -baten), de voorziening voor inkomstenbelasting, afschrijvingskosten en amortisatiekosten.
We define adjusted EBITDA as EBITDA adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including stock-based compensation, restructuring charges, impairment charges, settlement and fees of litigation matters, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.
We define adjusted net income as reported net income, adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including impairment charges, settlement and fees of litigation matters, restructuring charges, amortization of acquisition-related intangibles, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture, certain discrete tax items and non-GAAP income tax reconciling adjustments.
Wij definiëren de gecorrigeerde winst per aandeel als de gecorrigeerde nettowinst gedeeld door het gewogen gemiddelde aantal uitstaande verwaterde aandelen.
We definiëren het gecorrigeerde belastingtarief als het GAAP-belastingtarief, gecorrigeerd voor eenmalige belastingposten en het netto-effect van niet-GAAP-aanpassingen.
Het management is van mening dat deze niet-GAAP-conforme financiële maatstaven een aanvullend instrument vormen om de operationele prestaties op kwartaalbasis te beoordelen. Deze niet-GAAP-conforme financiële maatstaven bieden het management met name een aanvullend instrument om de operationele resultaten en trends in onze lopende bedrijfsactiviteiten te begrijpen en te beoordelen, door bepaalde niet-contante kosten en andere posten buiten beschouwing te laten die volgens het management anders de vergelijking van onze lopende bedrijfsactiviteiten met voorgaande periodes zouden bemoeilijken, trends in de lopende bedrijfsactiviteiten zouden verdoezelen of het vermogen van het management om bruikbare prognoses op te stellen zouden beperken.
In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors. However, these non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies. Management may, however, utilize other measures to illustrate performance in the future. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided below. These non-GAAP measures exclude (i) amortization of acquisition-related intangibles, (ii) restructuring charges, (iii) acquisition and integration costs, (iv) impairment charges, (v) foreign exchange gains/losses, (vi) interest income, (vii) benefit (provision) from income taxes, (viii) depreciation, (ix) amortization, (x) stock-based compensation, (xi) gain/loss on disposal of assets/divestiture, (xii) settlement and fees of litigation matters, (xiii) certain discrete tax items, and (xiv) non-GAAP income tax reconciling adjustments.
We hebben geen kwantitatieve afstemming verstrekt tussen de toekomstgerichte, niet-GAAP-conforme aangepaste winst per verwaterd aandeel en de aangepaste EBITDA enerzijds en de meest direct vergelijkbare GAAP-conforme financiële maatstaven anderzijds, omdat we niet in staat zijn om met redelijke zekerheid het uiteindelijke tijdstip of bedrag van bepaalde belangrijke posten in te schatten zonder onevenredige inspanningen. Dit is te wijten aan de inherente moeilijkheid om het tijdstip en/of het bedrag te voorspellen van diverse posten die van invloed zouden zijn op de aangepaste winst per verwaterd aandeel en de aangepaste EBITDA. Dit omvat posten die zich nog niet hebben voorgedaan, buiten de controle van de onderneming vallen, niet redelijkerwijs kunnen worden voorspeld en/of waarvoor er geen betekenisvolle aanpassing of verschil zou zijn. Om dezelfde redenen is de onderneming niet in staat om de waarschijnlijke significantie van de niet-beschikbare informatie te beoordelen.
Our non-GAAP tax provision for the fiscal third quarter of 2026 is 23%. The difference between our GAAP income tax provision and our non-GAAP income tax provision is presented as non-GAAP income tax reconciling adjustments.
| IPG PHOTONICS CORPORATION SUPPLEMENTAL SCHEDULE OF NON-GAAP MEASURES (UNAUDITED) |
||||||||||||||||
| Overzicht van de brutowinst naar de gecorrigeerde brutowinst en de gecorrigeerde brutomarge | ||||||||||||||||
| Drie maanden eindigend op 30 september, | Negen maanden eindigend op 30 september, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (in duizenden, behalve percentages) | ||||||||||||||||
| Brutowinst | $ | 117,054 | $ | 99,005 | $ | 329,077 | $ | 282,390 | ||||||||
| Brutomarge | 40.7 | % | 39.5 | % | 39.6 | % | 38.7 | % | ||||||||
| Afschrijving van immateriële activa in verband met overnames | 720 | 851 | 2,360 | 2,928 | ||||||||||||
| Kosten voor overnames en integratie | - | - | - | 482 | ||||||||||||
| Aangepaste brutowinst | $ | 117,774 | $ | 99,856 | $ | 331,437 | $ | 285,800 | ||||||||
| Aangepaste brutomarge | 41.0 | % | 39.8 | % | 39.9 | % | 39.2 | % | ||||||||
Reconciliation of Operating Expenses to Adjusted Operating Expenses
| Drie maanden eindigend op 30 september, | Negen maanden eindigend op 30 september, | |||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
| (in duizenden) | ||||||||||||
| Operating expenses | $ | 96,277 | $ | 91,150 | $ | 311,505 | $ | 272,604 | ||||
| Less: | ||||||||||||
| Afschrijving van immateriële activa in verband met overnames | 1,231 | 1,551 | 3,701 | 4,570 | ||||||||
| Kosten voor overnames en integratie | 151 | 246 | 987 | 1,823 | ||||||||
| Afschrijvingen wegens waardevermindering | 231 | - | 17,805 | - | ||||||||
| Herstructureringskosten | 149 | 425 | 500 | 425 | ||||||||
| Schikkingen en kosten in rechtszaken | - | - | 14,435 | - | ||||||||
| Wisselkoersverlies | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||
| Adjusted operating expenses | $ | 91,240 | $ | 87,424 | $ | 271,784 | $ | 258,773 | ||||
Reconciliation of Operating Income to Adjusted Operating Income
| Drie maanden eindigend op 30 september, | Negen maanden eindigend op 30 september, | |||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
| (in duizenden) | ||||||||||||
| Bedrijfsopbrengsten | $ | 20,777 | $ | 7,855 | $ | 17,572 | $ | 9,786 | ||||
| Afschrijving van immateriële activa in verband met overnames | 1,951 | 2,402 | 6,061 | 7,498 | ||||||||
| Kosten voor overnames en integratie | 151 | 246 | 987 | 2,305 | ||||||||
| Afschrijvingen wegens waardevermindering | 231 | - | 17,805 | - | ||||||||
| Herstructureringskosten | 149 | 425 | 500 | 425 | ||||||||
| Schikkingen en kosten in rechtszaken | - | - | 14,435 | - | ||||||||
| Wisselkoersverlies | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||
| Gecorrigeerd bedrijfsresultaat | $ | 26,534 | $ | 12,432 | $ | 59,653 | $ | 27,027 | ||||
Aansluiting van de nettowinst naar de aangepaste EBITDA
| Drie maanden eindigend op 30 september, | Negen maanden eindigend op 30 september, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (in duizenden) | ||||||||||||||||
| Netto-inkomen | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | ||||||||
| Rentebaten, netto | (7,688 | ) | (7,283 | ) | (21,720 | ) | (22,728 | ) | ||||||||
| Voorziening voor winstbelastingen | 8,142 | 8,191 | 14,876 | 16,714 | ||||||||||||
| Afschrijving | 12,986 | 12,392 | 38,447 | 36,120 | ||||||||||||
| Afschrijving | 2,976 | 3,240 | 8,930 | 10,679 | ||||||||||||
| EBITDA | $ | 36,689 | $ | 24,003 | $ | 67,632 | $ | 58,611 | ||||||||
| Afschrijvingen wegens waardevermindering | 231 | - | 17,805 | - | ||||||||||||
| Beloningen op basis van aandelen | 11,022 | 10,780 | 31,597 | 32,834 | ||||||||||||
| Herstructureringskosten | 149 | 425 | 500 | 425 | ||||||||||||
| Kosten voor overnames en integratie | 151 | 246 | 987 | 2,305 | ||||||||||||
| Schikkingen en kosten in rechtszaken | - | - | 14,435 | - | ||||||||||||
| Wisselkoersverlies | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||||||
| Aangepaste EBITDA | $ | 51,517 | $ | 36,958 | $ | 135,249 | $ | 101,188 | ||||||||
Aansluiting tussen de nettowinst volgens GAAP en de nettowinst volgens non-GAAP, en tussen de nettowinst per aandeel volgens GAAP en de nettowinst per aandeel volgens non-GAAP (verwaterd)
| Drie maanden eindigend op 30 september, | Negen maanden eindigend op 30 september, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (in duizenden, behalve gegevens per aandeel) | ||||||||||||||||
| Netto-inkomen | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | ||||||||
| Afschrijvingen wegens waardevermindering | 231 | - | 17,805 | - | ||||||||||||
| Afschrijving van immateriële activa in verband met overnames | 1,951 | 2,402 | 6,061 | 7,498 | ||||||||||||
| Herstructureringskosten | 149 | 425 | 500 | 425 | ||||||||||||
| Kosten voor overnames en integratie | 151 | 246 | 987 | 2,305 | ||||||||||||
| Schikkingen en kosten in rechtszaken | - | - | 14,435 | - | ||||||||||||
| Wisselkoersverlies | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||||||
| Bepaalde afzonderlijke belastingposten | 949 | 3,414 | 84 | 8,303 | ||||||||||||
| Fiscale gevolgen van niet-GAAP-aanpassingen | (711 | ) | (613 | ) | (5,337 | ) | (2,471 | ) | ||||||||
| Aangepaste nettowinst | $ | 26,268 | $ | 14,841 | $ | 63,927 | $ | 40,899 | ||||||||
| Aangepaste nettowinst per verwaterd aandeel | $ | 0.61 | $ | 0.35 | $ | 1.49 | $ | 0.96 | ||||||||
| Gewogen gemiddelde aantal uitstaande verwaterde aandelen | 42,840 | 42,556 | 42,904 | 42,659 | ||||||||||||
Aansluiting tussen het effectieve belastingtarief volgens GAAP en het effectieve belastingtarief volgens non-GAAP
| Drie maanden eindigend op 30 september, | Negen maanden eindigend op 30 september, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Belastingtarief | 29 | % | 52 | % | 35 | % | 48 | % | ||||||||
| Afzonderlijke belastingposten | (3 | ) | % | (22 | ) | % | - | % | (24 | ) | % | |||||
| Netto-effect van niet-GAAP-aanpassingen | (3 | ) | % | (3 | ) | % | (11 | ) | % | (3 | ) | % | ||||
| Aangepast belastingtarief | 23 | % | 27 | % | 24 | % | 21 | % | ||||||||
